Page 1 of Clinical Trials for Open-label extension, 2507 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease
Last Updated: August 30, 2011
Condition(s): Early Stage Parkinson's Disease
2
Completed
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease
Last Updated: March 28, 2012
Condition(s): Advanced Stage Parkinson's Disease
3
Completed
An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease
Last Updated: August 30, 2011
Condition(s): Idiopathic Parkinson's Disease
4
Completed
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease
Last Updated: August 30, 2011
Condition(s): Parkinson's Disease
5
Completed
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.
Last Updated: August 30, 2011
Condition(s): Early-Stage Parkinson's Disease
6
Completed
Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects
Last Updated: September 3, 2010
Condition(s): Hypertriglyceridemia
7
Terminated
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Last Updated: April 12, 2012
Condition(s): Alzheimer's Disease; Mild-to-moderate Alzheimers Disease
8
Completed
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
Last Updated: June 29, 2010
Condition(s): Diabetic Macular Oedema
9
Completed
A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
Last Updated: January 22, 2011
Condition(s): Hypertriglyceridemia
10
Recruiting
A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients With a 12 Week Open-label Extension
Last Updated: January 17, 2012
Condition(s): Rheumatoid Arthritis
11
Completed
Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)
Last Updated: October 14, 2011
Condition(s): Restless Legs Syndrome
12
Completed
An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Last Updated: April 26, 2011
Condition(s): Epilepsy; Complex Partial Seizures; Epilepsy, Complex Partial; Epilepsies, Partial
13
Completed
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
Last Updated: April 21, 2011
Condition(s): Epilepsy; Epilepsies, Partial
14
Active, not recruiting
Open-label Extension to Protocol 1042-0600
Last Updated: April 18, 2012
Condition(s): Epilepsies, Partial
15
Completed
An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
Last Updated: October 15, 2008
Condition(s): Bipolar Disorder
16
Completed
Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: October 28, 2011
Condition(s): Alzheimer's Disease
17
Completed
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Last Updated: September 13, 2011
Condition(s): Obesity
18
Active, not recruiting
Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
Last Updated: August 26, 2009
Condition(s): Refractory Partial Onset Seizures
19
Active, not recruiting
Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease
Last Updated: July 13, 2007
Condition(s): Alzheimer's Disease
20
Completed
Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
Last Updated: April 19, 2012
Condition(s): Alzheimer's Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Open-label+extension

Page 1 of Clinical Trials for Open-label extension, 2507 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About